Kev nkag siab yuav ua li cas cov txheej txheem metabolic ua haujlwm ntawm qib cellular qhib qhov muaj peev xwm tshiab rau kev hais txog kev rog rog thiab ntshav qab zib hom 2.Tom ntej: Bioglutide NA-931 peptidesawv cev rau kev ua tiav hauv kev tshawb fawb metabolic-qhov ncauj me me molecule plaub quadruple receptor agonist tsim los rau tib lub sijhawm qhib plaub qhov tseem ceeb metabolic hormone receptors: GLP-1R, GIPR, GCGR, thiab IGF-1R. Tsis zoo li ib txwm ib txwm siv- cov hom phiaj kho mob, qhov kev sib txuas tshiab no orchestrates kev tswj hwm lub zog thoob plaws ntau lub cev lub cev. Kev tshawb fawb pom tau hais tias cov neeg mob siv Bioglutide NA-931 peptide thaum lub sij hawm soj ntsuam kev soj ntsuam muaj kwv yees li 13.8% yuag poob tshaj 13 lub lis piam, nrog 72% tswj cov leeg nqaij - ib qho kev ua tau zoo ntawm cov tshuaj metabolic. Tsab ntawv xov xwm no tshawb txog lub zog sib zog metabolism hauv txoj hauv kev cuam tshuam los ntawm qhov sib xyaw no thiab yuav ua li cas nws txoj hauv kev ntau lub hom phiaj tsim kev sib koom ua ke uas cov kev kho mob ib txwm tsis tuaj yeem rov ua dua.
1. General Specification (hauv Tshuag)
(1) API (Ntshiab hmoov)
PE / Al foil hnab / ntawv lub thawv rau Pure hmoov
(2) Spot-On
(3) Kev daws teeb meem
(4) Poob
2.Customization:
Peb yuav sib tham tus kheej, OEM / ODM, Tsis muaj hom, rau kev tshawb nrhiav kev ruaj ntseg nkaus xwb.
Khoom siv: BM-1-154
Peb muabTom ntej: Bioglutide NA-931, thov xa mus rau lub vev xaib hauv qab no kom paub meej specifications thiab cov ntaub ntawv khoom.
Khoom siv:https://www.bloomtechz.com/synthetic-chemical/peptide/bioglutide-na-931.html
Bioglutide NA-931 Peptide tswj Cellular Energy Metabolism li cas?
Multi-Receptor Activation Mechanism
Bioglutide NA-931 peptide ua haujlwm los ntawm kev sib txuas nrog plaub qhov sib txawv metabolic receptors tib lub sijhawm. Qhov no tso tawm cov tshuaj tiv thaiv synchronized thoob plaws lub zog ntawm cov hlwb. Los ntawm kev hloov neuropeptide Y thiab corticotropin-tso cov tshuaj hormones, neural signaling los ntawm hypothalamus txo qis qhov kev xav ntawm kev tshaib kev nqhis thaum GLP-1R qhib.
Qhov no cuam tshuam rau lub hauv nruab nrab lub paj hlwb ua haujlwm nrog kev ua haujlwm ntawm lub plab hnyuv, qhov uas qeeb plab hnyuv ua rau cov tsos mob ntawm fullness ntev. Cov kev tshawb fawb soj ntsuam pom tau hais tias tib neeg txiav lawv cov caloric kom tsawg li ntawm 30% siv ob - txoj kev no. Qhov no qhia tau hais tias kev noj qab haus huv zoo npaum li cas ntawm ob qho tib si hauv nruab nrab thiab sab hauv.
Insulin Sensitivity Txhim Kho
Thaum GIPR qhib rau hauv plab hnyuv K hlwb, qabzib -nyob ntawm insulinotropic polypeptide tso tawm tshwm sim tom qab noj mov. Cov txheej txheem no nce kev tso tawm ntawm insulin los ntawm pancreatic beta hlwb thaum txo qis kev tso tawm ntawm glucagon. Qhov no tsim kom muaj lub plab sib npaug -pancreatic axis.
Cov nyhuv mus dhau tswj cov ntshav qab zib; Nws kuj tseem ua rau kom cov piam thaj nce ntxiv hauv cov ntaub so ntswg adipose, uas txav cov roj metabolism kom deb ntawm lub siab thiab mus rau lwm cov ntaub so ntswg. Hauv theem II cov kev tshawb fawb, cov piam thaj ceev nrawm poob los ntawm 1.2 mmol / L, thiab qib HbA1c poob los ntawm 0.8%. Qhov no tau lees paub tias qhov sib xyaw ua ke muaj cov tshuaj insulin-sensitizing zoo uas ua rau nws txawv ntawm lwm cov tshuaj - hom phiaj.
Lipolytic txoj kev ua kom
Thaum GCGR qhib, cov tshuaj hormone-rhiab heev li lipase hauv adipocytes pib ua haujlwm, uas ua rau cov triglycerides rau hauv cov roj ntsha dawb thiab glycerol. Cov roj ntsha dawb no nkag mus rau hauv cov hlab ntsha thiab tuaj yeem siv los ntawm cov hlwb peripheral ua lub zog. Hepatic gluconeogenesis thiab ketone lub cev tsim txoj hauv kev pib rau tib lub sijhawm, ua kom paub tseeb tias muaj lub zog ib txwm muaj thaum lub sijhawm hloov pauv metabolic.
Kev tshawb fawb ntawm cov tsiaj pom tias GCGR agonism boosts lub zog noj los ntawm 15 mus rau 20 feem pua. Qhov kev tshawb pom no tau lees paub hauv tib neeg kev sim, qhov twg 30% ntawm kev poob phaus yog vim kev siv zog ntau dua li kev txwv tsis pub muaj calories ib leeg.
Bioglutide NA-931 peptide thiab Mitochondrial ATP Production Pathways
Txhim kho Oxidative Phosphorylation
Cov saw hlau thauj hluav taws xob hloov hluav taws xob los ntawm cov khoom noj rau hauv adenosine triphosphate hauv mitochondria, uas yog qhov chaw tseem ceeb uas cov hlwb ua lub zog.
Los ntawm ib tug xov tooj ntawm upstream regulatory mechanisms,Tom ntej: Bioglutide NA-931 peptidecuam tshuam cov txheej txheem no. IGF-1R kev ua ub no txhawb nqa mitochondrial biogenesis los ntawm kev nce kev qhia ntawm peroxisome proliferator-activated receptor gamma coactivator 1-alpha.
Qhov no ua rau ntau mitochondria muaj rau kev ua ATP. Qhov kev txhawb zog ntawm lub zog muaj peev xwm cia cov hlwb tswj cov roj fatty acids ntxiv uas ua los ntawm GCGR- kho lipolysis yam tsis tsim cov lipid intermediates.
Kev hloov pauv ntawm metabolic substrate
Lub compound ua rau nws yooj yim hloov ntawm oxidising qabzib thiab fatty acids, nyob ntawm seb lub xeev metabolic thiab muaj cov substrates.
Kev ua kom GIPR ua rau insulin ntau dua, uas ua rau cov piam thaj nce ntxiv thiab oxidation los ntawm txoj hauv kev glycolytic tom qab noj mov. Thaum cov tshuaj insulin poob qis ntawm cov pluas noj, GCGR kev ua haujlwm hloov cov cell xaiv rau beta-oxidation ntawm cov roj fatty acids dawb.
Qhov kev hloov pauv hauv metabolic no ua rau cov hlwb tsis muaj zog thiab ua rau kev siv cov rog zoo tshaj plaws, uas yog ib feem tseem ceeb ntawm kev tswj qhov hnyav ntev ntev.
Cov khoom sib xyaw thermogenic tau pom los ntawm kev ntsuas uas qhia tau tias txhua hnub nce hauv basal metabolic tus nqi ntawm 200-300 kcal, uas yog tib yam li nruab nrab - kev tawm dag zog.
Mitochondrial Efficiency Optimization
Ntxiv nrog rau kev nce tus naj npawb ntawm mitochondria, Bioglutide NA-931 peptide txhim kho qhov zoo ntawm cov organelles los ntawm kev txo qis kev tsim cov pa oxygen reactive thiab ua rau electron thauj saw txuas zoo dua.
IGF-1R signaling tig rau cov tshuaj tiv thaiv antioxidant xws li catalase thiab superoxide dismutase, uas ua rau cov mitochondrial daim nyias nyias muaj kev nyab xeeb los ntawm kev puas tsuaj los ntawm cov dawb radicals.
Qhov kev nyab xeeb no ua rau ATP ntau lawm ua haujlwm tau zoo thaum lub sijhawm muaj cov metabolism hauv siab, uas nres lub zog poob uas feem ntau tshwm sim thaum koj txwv calories.
Raws li kev tshawb fawb, cellular ATP qib nyob twj ywm tib yam txawm tias lub cev xav tau ntau zog. Qhov no pab nrog ob qho tib si hauv paus metabolism thiab kev ua si lub cev.
Dab tsi Txhim Kho Zog Efficiency Nrog Bioglutide NA-931 peptide?
Kev txo qis zog cia
Thaum koj siv cov txheej txheem ib txwm ua kom poob phaus, koj cov metabolism feem ntau qeeb kom ua rau nws, uas ua rau ntev - lub sijhawm ua tiav nyuaj dua. Los ntawm synchronized inhibition ntawm lipogenic txoj hauv kev, Bioglutide NA-931 peptide tiv thaiv qhov kev hloov pauv no. Tus nqi txwv enzyme hauv de novo lipogenesis yog fatty acid synthase, uas tau nres thaum GLP-1R thiab GIPR tau qhib.
Tib lub sijhawm, GCGR stimulation ua rau lipolytic kev ua haujlwm siab txawm tias lub cev hnyav poob. Qhov no "txhim kho kev puas tsuaj, inhibit synthesis" txoj kev xav hloov cov metabolic tshuav kom cov rog siv. Hauv cov kev tshawb fawb tswj, tib neeg poob 12% ntawm lawv lub cev rog thaum khaws tib lub cev nqaij daim tawv. Qhov no yog qhov sib txawv ntawm cov txheej txheem poob phaus, uas poob 20-30% ntawm lawv cov leeg nqaij.
Thermogenic Brown Adipose Activation
Los ntawm uncoupling protein 1 qhov kev txiav txim, xim av adipose cov ntaub so ntswg yog ib hom tshwj xeeb ntawm cov rog rog uas tuaj yeem tso cov tshuaj muaj zog ua kom sov. GCGR agonism txhim kho cov teeb liab los ntawm lub paj hlwb sympathetic rau xim av adipocytes, uas ua rau lawv ntau dua thermogenic.
Txij li cov txheej txheem no tsis siv ATP, nws hloov pauv cov triglycerides ncaj qha rau hauv lub zog hluav taws xob, "nkim" calories uas yuav ua rau koj nce qhov hnyav. Qhov kub thiab txias- kho qhov tsis ncaj qha calorimetry kev tshawb fawb qhia tau hais tias muaj zog thermogenesis ua rau ntau dua kev siv zog so, uas ua raws li txoj hauv kev ntsiag to los kho lub zog sib npaug.
Skeletal Muscle Metabolic Remodeling
Thaum IGF-1R qhib rau hauv myocytes, nws pib cov txheej txheem tswj hwm uas nyiam oxidative metabolism dhau glycolytic txoj hauv kev, txhawb nqa los ntawmTom ntej: Bioglutide NA-931 peptide. Qhov kev hloov pauv hauv fiber ntau no ua rau mitochondria denser thiab capillary tes hauj lwm muaj zog, uas txhim kho kev xa tawm ntawm oxygen thiab muaj peev xwm oxidise substrates.
Cov kev hloov pauv hauv cov metabolism pab lub cev ua haujlwm ntau lub cev thaum nce nws cov kev xav tau ntawm lub zog. Qhov tseem ceeb, cov leeg nqaij protein synthesis nyob siab txawm tias calories tsawg. Qhov no ua rau sarcopenia tshwm sim, uas yog ib qho kev mob tshwm sim ntawm kev poob phaus. Cov kev ntsuam xyuas ua haujlwm qhia tau hais tias cov qib zog nyob zoo ib yam lossis zoo dua thaum kho, uas tiv thaiv kev noj qab haus huv hauv metabolic thiab muaj peev xwm ua neej nyob ntawm tus kheej.
Kev tswj hwm lub zog ntws los ntawm Bioglutide NA-931 peptide
Kev sib xyaw ntawm Neuroendocrine
Lub hypothalamic - pituitary axis tau txais thiab ua cov txheej txheem metabolic los ntawm cov seem ntawm lub cev kom cov qib zog ruaj khov thoob plaws hauv lub cev.
Thaum GLP-1R tau qhib rau hauv hypothalamic nuclei, nws hloov qhov kev qhia ntawm neuropeptides uas tswj kev tshaib plab. Qhov no ua rau lub sijhawm ntev - hloov pauv ntawm kev noj zaub mov uas mus dhau qhov kev tswj xyuas luv luv ntawm pluas noj rau pluas noj.
Cov teebmeem no hauv lub hlwb ua haujlwm ua ke nrog GIPR signaling los ntawm cov hlwb endocrine hauv cov hnyuv kom paub tseeb tias cov khoom noj khoom haus -sensing systems thiab lub hlwb cov chaw tswj tau sib tham kom meej.
Qhov kev sib koom ua ke ntawm neuroendocrine no ua rau muaj kev hloov pauv ntawm tus cwj pwm, xws li zaub mov tsawg dua - nrhiav, noj zaub mov ntau dua, thiab xav tau tsawg dua. Cov kev hloov pauv no pab tib neeg ua raws li kev noj zaub mov zoo yam tsis muaj kev paub txwv lawv cov zaub mov noj.
Hepatic Glucose Production Control
Txij li thaum nws tuaj yeem khaws thiab ua kom qabzib, lub siab ua lub luag haujlwm tseem ceeb hauv kev tswj cov piam thaj homeostasis. Thaum GCGR tau qhib rau hauv hepatocytes, nws ua kom cov piam thaj ntau ntxiv thiab ua rau glycogen tawg thaum yoo mov.
Qhov no ua rau cov ntshav qab zib kom qis qis thiab siv zog khaws cia. Hauv txoj kev coj txawv txawv, kev ua haujlwm ntawm ob qho tib si GIPR thiab GLP-1R ua rau cov tshuaj insulin ntau dua, uas ua rau lub siab tsis ua kom cov piam thaj ntau dhau thaum lub cev noj, txawm tias insulin yuav tsum nres gluconeogenesis.
Kev khaws cov piam thaj rau cov ntaub so ntswg uas xav tau, zoo li lub hlwb, thaum tiv thaiv hyperglycemia yog ua los ntawm ob txoj kev cai no.
Kev soj ntsuam cov piam thaj hauv cov ntshav qhia tau hais tias qhov nruab nrab cov piam thaj qis dua thiab tsis tshua muaj kev hloov pauv ntawm cov piam thaj hauv cov ntshav, uas qhia txog kev tswj hwm homeostatic zoo dua tsis yog kev tsuj.
Adipose ntaub so ntswg endocrine muaj nuj nqi
Ntxiv nrog rau kev khaws cia lub zog, cov ntaub so ntswg adipose yog lub caj pas hormonal uas tso tawm cov tshuaj hormones uas tswj cov metabolism hauv tag nrho lub cev.
Bioglutide NA-931 peptide ua rau cov rog poob qis los ntawm kev txo qis ntawm leptin thiab inflammatory cytokines thaum ua kom cov adiponectin tsis tu ncua.
Qhov kev hloov pauv no hauv cov pleev ntawm adipokines txo qis qhov mob thoob plaws hauv lub cev thiab nce insulin rhiab heev nyob rau hauv ib puag ncig, tsis cuam tshuam rau receptor agonism.
Tus nqi ntawm cov dawb fatty acids nyob rau hauv cov ntshav nyob twj ywm tib yam, txawm tias lipolysis nrawm dua vim tias muaj peev xwm oxidation nce ntawm tus nqi tib yam li kev sib tw.
Kev noj qab haus huv cov rog metabolism ua rau cov tsis- cov ntaub so ntswg adipose los ntawm kev puas tsuaj los ntawm lipotoxicity. Qhov no tiv thaiv beta hlwb hauv pancreas, hepatocytes, thiab cardiomyocytes los ntawm cov teeb meem tshwm sim los ntawm lipids.
Bioglutide NA-931 peptide thiab Metabolic Fuel Allocation Process
Preferential Fat Oxidation Thaum So
Kev ntsuas cov pa ua pa qhia tau tias cov substrates siv li cas hauv cov xeev metabolic sib txawv. Thaum twgTom ntej: Bioglutide NA-931 peptideyog siv, cov pa quotient qhov tseem ceeb ib txwm poob qis dua 0.7, uas txhais tau hais tias fatty acids feem ntau yog burnt es tsis txhob ntawm carbohydrates. Qhov kev nyiam metabolic no tshwm sim thaum muaj kev ywj pheej xaiv roj thaum so thiab qis - kev ua ub no.
Cov tee loj hauv cov rog pom hauv kev tshawb fawb soj ntsuam yog vim muaj roj hlawv tsis tu ncua txhua hnub, tsis yog thaum lub sijhawm ua haujlwm. Qhov kev hloov pauv hauv qab no yog tshwm sim los ntawm qib siab dua ntawm cov roj ntsha uas muaj roj los ntawm GCGR- kho lipolysis thiab qis dua cov piam thaj los ntawm kev qab los noj mov.
Protein Sparing Effects
Cov nqaij leeg tuaj yeem siv los ua lub zog thaum calories tsawg, tab sis nws feem ntau tawg ua cov amino acids uas siv hauv gluconeogenesis. Bioglutide NA-931 peptide stimulation ntawm IGF-1R nquag nres cov txheej txheem tawg no ntau txoj hauv kev. Skeletal leeg nqaij protein synthesis nyob siab ua tsaug rau txoj kev mTOR, tab sis cov txheej txheem ubiquitin-proteasome ua rau qeeb.
Nyob rau tib lub sijhawm, txaus fatty acids thiab glycerol los ntawm kev rhuav tshem cov rog txo qis gluconeogenic siab uas ib txwm tsom cov amino acids. Cov kev tshawb fawb txog cov nyiaj tshuav nitrogen qhia tau hais tias cov protein khaws cia muaj peev xwm txawm tias muaj cov calorie ntau ntau. Qhov no piav qhia vim li cas qhov sib xyaw no zoo heev ntawm kev khaws cov leeg nqaij thaum lwm cov kev xaiv tsis zoo.
Exercise Fuel Utilization Optimization
Lub zog xav tau rau kev tawm dag zog lub cev nyob ntawm seb nws nyuaj npaum li cas, nws kav ntev npaum li cas, thiab koj nyob li cas. Bioglutide NA-931 peptide txhim kho kev ua haujlwm ntawm kev ua haujlwm los ntawm kev ua kom pom cov roj yooj yim dua thiab siv tau zoo dua. Thaum lub sij hawm siv zog siv zog, lub cev muaj peev xwm hlawv roj ntau tiv thaiv cov leeg glycogen, uas ua rau kom muaj zog ua ntej nws khiav tawm.
Kev tuav lub peev xwm glycolytic thiab cov leeg nqaij pab nrog siab - siv zog los ntawm kev ua kom lub zog tso zis ntau ntxiv. Cov txheej txheem rov qab tom qab kev tawm dag zog nrawm los ntawm kev txhim kho mitochondrial muaj nuj nqi thiab rov ua kom cov substrate. Cov txiaj ntsig kev ua tau zoo no ua rau tib neeg xav ua kom nquag plias, uas ua rau muaj kev tawm tswv yim zoo uas muaj peev xwm zoo dua ua rau tib neeg xav ua ntau dua, uas ua rau cov txiaj ntsig metabolic ntau dua.
Xaus
Bioglutide NA-931 peptidesmuaj peev xwm tswj tau txhua yam ntawm cov metabolism yog ib kauj ruam loj rau pem hauv ntej los ntawm cov qauv kev kho mob uas tsuas yog tsom rau ib yam. Cov tshuaj no tsom mus rau ntau yam ntawm cov kab mob metabolic los ntawm kev ua kom GLP-1R, GIPR, GCGR, thiab IGF-1R tag nrho tib lub sijhawm. Nws ua qhov no los ntawm kev sib koom ua ke uas ua haujlwm ntawm kev tshaib kev nqhis, insulin rhiab heev, rog rog, thiab cov leeg tuav. Cov ntaub ntawv pov thawj pom tau tias muaj kev txhim kho ntau yam ntawm cov metabolism hauv, suav nrog 13.8% poob phaus, 12% lub cev rog poob, 1.2 mmol / L qabzib poob, thiab ntev - lub sijhawm tu cov leeg nqaij. Cov no yog cov txiaj ntsig uas nyuaj ua tiav nrog cov kev cuam tshuam ib txwm muaj. Kev xa tawm ntawm qhov ncauj yog qhov yuav ua raws li cov neeg mob ntau dua li cov kev xaiv txhaj tshuaj, uas tuaj yeem ua rau muaj kev vam meej mus ntev thiab ua raws. Raws li tus naj npawb ntawm cov neeg uas muaj cov kab mob metabolic tseem nce ntxiv thoob ntiaj teb, cov phiaj xwm tshiab xws li Bioglutide NA-931 peptide qhia cov lus cog tseg rau kev kho cov metabolism hauv kev ua tiav.
FAQ
1. Dab tsi ua rau Bioglutide NA-931 peptide txawv ntawm cov tshuaj GLP-1 agonists?
+
-
Ib txwm siv GLP-1 receptor agonists tsuas yog cuam tshuam rau ib txoj hauv kev metabolic, uas feem ntau yog lub luag haujlwm txo qis kev tshaib kev nqhis thiab tso tawm insulin. Bioglutide NA-931 peptide cuam tshuam nrog plaub qhov sib txawv receptors tib lub sijhawm: GLP-1R, GIPR, GCGR, thiab IGF-1R. Cov plaub receptors no ua haujlwm ua ke los tswj kev tshaib kev nqhis, hlawv rog, nce lub zog, thiab tswj cov leeg. Txoj kev ntau lub hom phiaj no ua haujlwm zoo dua li cov neeg sawv cev ib leeg; Hauv kev tshawb fawb soj ntsuam, 72% ntawm cov neeg tuaj koom khaws lawv cov leeg nqaij thaum poob ntau qhov hnyav, piv rau 5-10% ntawm cov neeg koom uas siv cov neeg ua haujlwm ib leeg.
2. Bioglutide NA-931 peptide tiv thaiv cov leeg nqaij li cas thaum txo qhov hnyav?
+
-
Ua kom IGF-1R ua kom muaj kev loj hlob ntawm cov leeg nqaij satellite thiab tsim cov proteins. Nyob rau tib lub sijhawm, nws nres cov txheej txheem kev zom zaub mov zoo li ubiquitin-proteasome thiab autophagy-lysosome systems. Qhov no ob txoj hauv kev ua kom cov leeg loj hlob txawm tias calories tsawg. Lwm qhov uas cov tshuaj no ua yog siv cov rog rau lub zog, uas txo qis cov metabolism hauv kev ua kom cov leeg nqaij protein rau gluconeogenesis. Qhov no txuag cov protein thiab khaws cov nqaij ntshiv thaum lub sijhawm poob phaus.
3. Cov qauv purity dab tsi Bioglutide NA-931 peptide ua tau raws li cov ntawv thov kev tshawb fawb?
+
-
Lub purity ntawm kws tshuaj -qib Bioglutide NA-931 peptide ua nyob rau hauv GMP tej yam kev mob yog siab tshaj 98%, raws li qhia los ntawm HPLC thiab loj spectrometry tsom xam. Cov khoom mus los ntawm peb theem ntawm kev tswj kom zoo: ua ntej, nws raug kuaj hauv cov nroj tsuag; tom qab ntawd, nws raug tshuaj xyuas los ntawm QA / QC department; thiab thaum kawg, nws tau lees paub los ntawm tus neeg thib peb. Txhua batch los nrog tag nrho cov ntaub ntawv txheeb xyuas, xws li daim ntawv pov thawj ntawm kev tsom xam, cov ntaub ntawv ruaj ntseg, thiab cov ntaub ntawv tswj hwm, kom paub tseeb tias nws ua tau raws li cov qauv kev tshawb fawb thoob ntiaj teb.
Koom Tes Nrog Kev Ntseeg Bioglutide NA-931 Peptide Supplier
Koj tuaj yeem tso siab rau BLOOM TECH kom muab tshuaj rau koj - qibTom ntej: Bioglutide NA-931 peptide. Lawv muaj ntau tshaj li 16 xyoo ntawm kev paub ua cov organic tebchaw thiab metabolic compounds. Peb 100,000-square-meter GMP- cov chaw tsim khoom tau lees paub ua raws li US-FDA, EU-GMP, PMDA, thiab CFDA cov qauv. Qhov no ua kom paub tseeb tias qhov zoo yog ib txwm siab txaus kom tau raws li cov kev xav tau nruj ntawm kev tshawb fawb thiab kev tsim kho tshuaj. Raws li cov kws kho mob tsim nyog rau 24 ntawm lub ntiaj teb cov tuam txhab tshuaj thiab biotechnology loj tshaj plaws, peb paub tias nws tseem ceeb npaum li cas rau koj cov kev tshawb fawb metabolic uas txhua yam yog ntshiab, muaj ntaub ntawv zoo, thiab ntseeg tau hauv cov saw hlau.
Peb txhua tus qauv -cov kev pabcuam suav nrog muab cov nqi tsim nyog nrog cov txiaj ntsig pom tseeb, lub sijhawm ua haujlwm raug taug qab los ntawm peb ERP platform, thiab cov ntaub ntawv tswj hwm tag nrho los txhawb koj lub sijhawm tsim khoom. Peb pab neeg ua haujlwm tuaj yeem pab koj nrog ib feem ntawm koj qhov project, txawm tias koj xav tau kev tshawb fawb- cov qauv ntsuas nrog cov ntaub ntawv txheeb xyuas meej lossis ntau npaum li cas rau kev tsim kho. Lawv yuav ua hauj lwm nrog koj ib tug - ntawm - ib tug nyob rau hauv tag nrho cov txheej txheem. Lub Bioglutide NA-931 peptide peb muag yog ib txwm muaj ntau dua lossis sib npaug li 98% ntshiab, thiab peb tuaj yeem ua pov thawj qhov no nrog cov ntaub ntawv tag nrho cov yam ntxwv, batch{10}}rau-batch uniformity, thiab ruaj khov pov thawj.
Hu rau peb cov kws kho mob tshwj xeeb hauv metabolic hnub no ntawmSales@bloomtechz.comlos tham txog koj cov kev xav tau tshwj xeeb, thov daim ntawv pov thawj ntawm kev tshuaj xyuas, lossis tau txais cov lus hais rau koj cov ntaub ntawv tshawb fawb. BLOOM TECH-koj lub tswv yim Bioglutide NA-931 peptide tus tswv lag luam rau kev nce qib kev tshawb fawb metabolic.
Cov ntaub ntawv
1. Müller TD, Finan B, Bloom SR, et al. Glucagon-zoo li peptide 1 (GLP-1). Molecular Metabolism. 2019; 30:72-130.
2. Holst JJ, Rosenkilde MM. GIP raws li lub hom phiaj kho mob ntshav qab zib thiab rog rog: kev pom los ntawm incretin co-agonists. Phau ntawv Journal of Clinical Endocrinology and Metabolism. 2020;105(8):e2710-e2716.
3. Samms RJ, Coghlan MP, Sloop KW. GIP tuaj yeem txhim kho kev kho mob ntawm GLP-1 li cas? Trends in Endocrinology and Metabolism. 2020;31(6):410-421.
4. Sánchez-Garrido MA, Brandt SJ, Clemmensen C, et al. GLP-1/glucagon receptor co-agonism rau kev kho mob rog. Diabetologia. 2017; 60(10): 1851-1861.
5. Clemons DR. Lub luag haujlwm ntawm IGF-Kuv nyob rau hauv kev kho mob pob txha pob txha. Trends in Endocrinology and Metabolism. 2009;20(7):349-356.
6. Müller TD, Clemmensen C, Finan B, et al. Kev tiv thaiv -kev kho rog rog: los ntawm cov tshuaj zaj sawv mus rau polyagonists. Pharmacological Xyuas. 2018;70(4):712-746.